AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026 Initial data indicates significantly higher tracer uptake in patients with ...
Dr Ronald Mabubi, a neurosurgeon at JRRH, said in the past, nearly 90 percent of patients referred from the facility did not survive, largely due to delays in accessing specialised care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results